Sean Reyes, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 338 Howard Blvd, Newport, NC 28570 Phone: 252-223-5054 |
Mr. Gregory Damon Shanton, PA Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 420 Old Airport Rd, Newport, NC 28570 Phone: 252-528-4734 |
Breanna Mary Grace Acero, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 338 Howard Blvd, Newport, NC 28570 Phone: 252-223-5054 Fax: 252-223-4038 |
News Archive
Eli Lilly and Company today announced that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation to abemaciclib, a cyclin-dependent kinase (CDK) 4 and 6 inhibitor, for patients with refractory hormone-receptor-positive (HR+) advanced or metastatic breast cancer.
Initial findings from a multi-national open-label phase Ib study of inhibitory drug therapy for relapsed or refractory acute myeloid leukemia (AML) have demonstrated a complete response in up to 50 percent patients say researchers at The University of Texas MD Anderson Cancer Center.
One way to defeat an opponent is to cut off its supply lines. Tumors are no different. The supply lines for tumors are the blood vessels that ferry oxygen and nutrients to the cells. Restricting the blood vessels that feed tumor cells can shrink the tumor. A cross-institutional international team of scientists recently discovered a new, important step of the process that grows new blood vessels, a discovery that could lead to a new way to combat cancer.
Anyone who studied a little genetics in high school has heard of adenine, thymine, guanine and cytosine - the A,T,G and C that make up the DNA code.
› Verified 3 days ago